Falutz J, Mamputu JC, Potvin D, Moyle G, Soulban G, Loughrey H, Marsolais C, Turner R, Grinspoon S
New Insights and Promising Therapies
If you respond well to standard doses, using intensive doses just burns through expensive product faster without proportional benefit
If you're doing everything "right" for your petthe diet, the supplements, the protocolsbut theyre still struggling with gut issues, itchy skin, or mystery symptoms that come and go
People with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2 (MEN2) should not use GLP-1 receptor agonists because of potential tumor risks observed in animal studies